Latest filing published 29 Aug 2026 for Goldline Pharmaceutical, €0.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Swapan Khandelwal: trading record in brief
All filings by Swapan Khandelwal on record concern Goldline Pharmaceutical. Between 23 June 2026 and 29 August 2026, the trades on record add up to 2 filings.
Every open-market trade on record is a purchase: 2 purchases worth €24k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 29 August 2026 came the latest disclosure, an open-market purchase for €0 in Goldline Pharmaceutical. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Swapan Khandelwal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 78,000 shares0EquityMarket PurchaseSEBI:acac8a23dcc56294157c0b04c36ba2f0e6bced9aCanonical exit: 27 Nov 2026 (T+90)
- 60,000 shares@ ₹43.30100.0% of flowEquity SharesMarket PurchaseSEBI:90f4a7ebc212091df94a2999d9e406e953d1c696Canonical exit: 21 Sept 2026 (T+90)
2 of 2 declarations